Related Experiment Video
Updated: Jan 10, 2026

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis
Published on: March 28, 2025
Inflammatory Biomarkers of Asymptomatic and Symptomatic Tuberculosis
Denis Awany1, Dominique T Ariefdien1, Simon C Mendelsohn1
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Asymptomatic tuberculosis (TB) shares inflammatory markers with symptomatic TB but has distinct blood signatures. Biomarkers for symptomatic TB need optimization for effective asymptomatic TB screening.
Area of Science:
- Immunology
- Infectious Diseases
- Genomics
Background:
- A significant portion of tuberculosis cases are asymptomatic, with unknown biological underpinnings.
- Understanding asymptomatic tuberculosis is crucial for effective public health strategies.
Purpose of the Study:
- To characterize blood transcriptomic and proteomic profiles in asymptomatic versus symptomatic tuberculosis.
- To identify distinct biological signatures and potential sub-clusters within asymptomatic TB.
Main Methods:
- Blood samples were analyzed for transcriptomic and proteomic profiles from South African cohorts.
- Data integration of transcriptomic and proteomic information was performed.
- Sub-clustering analysis was used to identify distinct groups within asymptomatic TB.
Main Results:
- Asymptomatic TB exhibited shared inflammatory and innate immune pathway upregulation with symptomatic TB.
- Distinct sub-clusters within asymptomatic TB were identified, correlating with bacterial burden and disease severity.
- A novel blood transcriptomic signature for asymptomatic TB was discovered.
Conclusions:
- Asymptomatic TB shares some biological features with symptomatic TB but possesses unique characteristics.
- Current biomarkers for symptomatic TB may not be directly applicable to asymptomatic TB screening.
- Further optimization of biomarkers is necessary for community-based asymptomatic TB screening programs.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Myocarditis II: Clinical Features and Diagnostic Tests

